Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Am J Respir Crit Care Med Retrieve available abstracts of 96 articles: HTML format

Single Articles

July 2021
1. HUANG Y, Zhu M, Ji M, Fan J, et al
   Air Pollution, Genetic Factors and the Risk of Lung Cancer: A Prospective Study in the UK Biobank.
   Am J Respir Crit Care Med. 2021 Jul 12. doi: 10.1164/rccm.202011-4063.
   PubMed     Abstract available
   
   
   June 2021
2. KRISTO S, Zou T, Dexter EU, Pokharel S, et al
   Amyloid Nodules Masquerading as Multifocal Lung Cancer.
   Am J Respir Crit Care Med. 2021 Jun 25. doi: 10.1164/rccm.202010-3756.
   PubMed    
   
   
   
3. PINSKY P
   EHRs and Machine Learning for Early Detection of Lung Cancer and other Conditions: Thinking about the Path Ahead.
   Am J Respir Crit Care Med. 2021 Jun 7. doi: 10.1164/rccm.202104-1009.
   PubMed    
   
   
   May 2021
4. GESTHALTER Y, Kathuria H, Moazed F
   Smoking Cessation and Cancer.
   Am J Respir Crit Care Med. 2021;203:P24-P25.
   PubMed    
   
   
   April 2021
5. ONORATI I, Kambouchner M, Martinod E
   A Pigmented Lung Perivascular Epithelioid Cell Tumor.
   Am J Respir Crit Care Med. 2021;203:1023-1024.
   PubMed    
   
   
   
6. GOULD MK, Huang BZ, Tammemagi MC, Kinar Y, et al
   Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data.
   Am J Respir Crit Care Med. 2021 Apr 6. doi: 10.1164/rccm.202007-2791.
   PubMed     Abstract available
   
   
   March 2021
7. FORBES LM, Gu S, Badesch DB
   Surrogate Markers for Pulmonary Hypertension May Inform Prognosis in Lung Cancer.
   Am J Respir Crit Care Med. 2021 Mar 31. doi: 10.1164/rccm.202103-0740.
   PubMed    
   
   
   
8. TURNER RD, Birring SS
   Neurokinin-1 Receptor Inhibition and Cough.
   Am J Respir Crit Care Med. 2021;203:672-674.
   PubMed    
   
   
   
9. YAMADA D, Murakami M, Matsusako M, Tamura T, et al
   Pulmonary Tumor Thrombotic Microangiopathy Appearance on Dual-Energy Computed Tomography.
   Am J Respir Crit Care Med. 2021;203:759-760.
   PubMed    
   
   
   January 2021
10. EUL B, Cekay M, Pullamsetti SS, Tello K, et al
    Non-invasive Surrogate Markers of PH are Associated with Poor Survival in Lung Cancer Patients.
    Am J Respir Crit Care Med. 2021 Jan 7. doi: 10.1164/rccm.202005-2023.
    PubMed    
    
    
    
11. WILSON DO
    Risk-Stratifying Pulmonary Nodules.
    Am J Respir Crit Care Med. 2021;203:149-150.
    PubMed    
    
    
    
12. MASSION PP
    Reply to Wilson: Risk-Stratifying Pulmonary Nodules.
    Am J Respir Crit Care Med. 2021;203:150.
    PubMed    
    
    
    
13. BORCZUK AC
    Therapeutic Interception of Early Lung Adenocarcinoma Progression: Not Just How, but When?
    Am J Respir Crit Care Med. 2021;203:8-9.
    PubMed    
    
    
    
14. TREEKITKARNMONGKOL W, Hassane M, Sinjab A, Chang K, et al
    Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.
    Am J Respir Crit Care Med. 2021;203:90-101.
    PubMed     Abstract available
    
    
    December 2020
15. BAAH S, Reyes-Barron C, Ohene Baah NY
    A Rare Cause of Hemoptysis in a 20-Year-Old Man.
    Am J Respir Crit Care Med. 2020;202:e146-e148.
    PubMed    
    
    
    November 2020
16. STEAGALL WK, Moss J
    Needle in the Haystack: Finding the Elusive Lymphangioleiomyomatosis Cell.
    Am J Respir Crit Care Med. 2020;202:1329-1330.
    PubMed    
    
    
    
17. HARDING WC, Marcoux M, Casal RF, Bashoura L, et al
    Lung Nodule in a Patient with Multiple Myeloma.
    Am J Respir Crit Care Med. 2020;202:1458-1459.
    PubMed    
    
    
    
18. GUO M, Yu JJ, Perl AK, Wikenheiser-Brokamp KA, et al
    Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell.
    Am J Respir Crit Care Med. 2020;202:1373-1387.
    PubMed     Abstract available
    
    
    October 2020
19. RIVERA MP, Katki HA, Tanner NT, Triplette M, et al
    Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.
    Am J Respir Crit Care Med. 2020;202:e95-e112.
    PubMed     Abstract available
    
    
    September 2020
20. SMITH JA, Harle A, Dockry R, Holt K, et al
    Aprepitant For Cough in Lung Cancer: A Randomised Placebo-Controlled Trial and Mechanistic Insights.
    Am J Respir Crit Care Med. 2020 Sep 23. doi: 10.1164/rccm.202006-2359.
    PubMed     Abstract available
    
    
    August 2020
21. TAKIMOTO T
    Micronodular Pattern of Organizing Pneumonia or Hypersensitivity Pneumonia, Induced by an Immune Checkpoint Inhibitor?
    Am J Respir Crit Care Med. 2020 Aug 17. doi: 10.1164/rccm.202005-2104.
    PubMed    
    
    
    
22. YAMASAKI M, Taniwaki M, Kawamoto K, Matsumoto N, et al
    Reply to: Micronodular Pattern of Organizing Pneumonia or Hypersensitivity Pneumonia, Induced by an Immune Checkpoint Inhibitor?
    Am J Respir Crit Care Med. 2020 Aug 17. doi: 10.1164/rccm.202006-2177.
    PubMed    
    
    
    
23. LIANG NC, Visger TV, Devereaux A
    Mindfulness for Those with COPD, Asthma, Lung Cancer, and Lung Transplantation.
    Am J Respir Crit Care Med. 2020;202:P11-P12.
    PubMed    
    
    
    July 2020
24. LAM AC, Aggarwal R, Huang J, Varadi R, et al
    Point-Of-Care Spirometry Identifies High-Risk Individuals Excluded from Lung Cancer Screening.
    Am J Respir Crit Care Med. 2020 Jul 16. doi: 10.1164/rccm.202005-1742.
    PubMed    
    
    
    
25. PEIKERT T, Bartholmai BJ, Maldonado F
    Radiomics-based Management of Indeterminate Lung Nodules? Are We There Yet?
    Am J Respir Crit Care Med. 2020;202:165-167.
    PubMed    
    
    
    
26. MASSION PP, Antic S, Ather S, Arteta C, et al
    Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules.
    Am J Respir Crit Care Med. 2020;202:241-249.
    PubMed     Abstract available
    
    
    
27. LI J, Lu X, Liu F, Liang F, et al
    Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China.
    Am J Respir Crit Care Med. 2020 Jul 2. doi: 10.1164/rccm.202001-0002.
    PubMed     Abstract available
    
    
    June 2020
28. LIANG NC, Von Visger T, Devereaux A
    Mindfulness for those with COPD, Asthma, Lung Cancer and Lung Transplantation.
    Am J Respir Crit Care Med. 2020 Jun 22. doi: 10.1164/rccm.2020.
    PubMed    
    
    
    
29. PISANO C, O'Connor J, Krick S, Russell DW, et al
    A Fatal Case of Pneumocephalus during Computed Tomography-guided Lung Biopsy.
    Am J Respir Crit Care Med. 2020;201:e83-e84.
    PubMed    
    
    
    
30. QUAIFE SL, Ruparel M, Dickson JL, Beeken RJ, et al
    Reply to: Improving Lung Cancer Screening Uptake.
    Am J Respir Crit Care Med. 2020 Jun 11. doi: 10.1164/rccm.202005-1699.
    PubMed    
    
    
    
31. WILSON DO
    Improving Lung Cancer Screening Uptake.
    Am J Respir Crit Care Med. 2020 Jun 11. doi: 10.1164/rccm.202004-1486.
    PubMed    
    
    
    May 2020
32. HE H, Long Y, Frerichs I, Zhao Z, et al
    Detection of Acute Pulmonary Embolism by Electrical Impedance Tomography and Saline Bolus Injection.
    Am J Respir Crit Care Med. 2020 May 29. doi: 10.1164/rccm.202003-0554.
    PubMed    
    
    
    
33. JUTANT EM, Jais X, Girerd B, Savale L, et al
    Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
    Am J Respir Crit Care Med. 2020 May 21. doi: 10.1164/rccm.202001-0105.
    PubMed     Abstract available
    
    
    
34. PENG M, Shi J, Feng R
    Multicentric Castleman Disease as a Rare Cause of Diffuse Lung Cysts.
    Am J Respir Crit Care Med. 2020;201:1292-1293.
    PubMed    
    
    
    
35. LIM KH, Silverstone EJ, Yates DH
    Multifocal Micronodular Pneumocyte Hyperplasia in Tuberous Sclerosis Complex: Resolution with Everolimus Treatment.
    Am J Respir Crit Care Med. 2020;201:e76.
    PubMed    
    
    
    
36. CHRISTIANI DC
    Occupational Exposures and Lung Cancer.
    Am J Respir Crit Care Med. 2020 May 12. doi: 10.1164/rccm.202004-1404.
    PubMed    
    
    
    April 2020
37. GE C, Peters S, Olsson A, Portengen L, et al
    Diesel Engine Exhaust Exposure, Smoking, and Lung Cancer Subtype Risks: A Pooled Exposure-response Analysis of 14 Case-control Studies.
    Am J Respir Crit Care Med. 2020 Apr 24. doi: 10.1164/rccm.201911-2101.
    PubMed     Abstract available
    
    
    
38. GE C, Peters S, Olsson A, Portengen L, et al
    Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks: A Pooled Analysis of Case-control Studies.
    Am J Respir Crit Care Med. 2020 Apr 24. doi: 10.1164/rccm.201910-1926.
    PubMed     Abstract available
    
    
    
39. QUAIFE SL, Ruparel M, Dickson JL, Beeken RJ, et al
    Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials.
    Am J Respir Crit Care Med. 2020;201:965-975.
    PubMed     Abstract available
    
    
    March 2020
40. PENNYCUICK A, Janes SM
    On the Origin of Lung Cancers.
    Am J Respir Crit Care Med. 2020;201:646-647.
    PubMed    
    
    
    
41. QIAN J, Zhao S, Zou Y, Rahman SMJ, et al
    Genomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma.
    Am J Respir Crit Care Med. 2020;201:697-706.
    PubMed     Abstract available
    
    
    
42. CHERIAN SV, Gill BS, Irani AD, Estrada-Y-Martin RM, et al
    Empyema "Necessitated" by Indwelling Pleural Catheter: A Unique Complication.
    Am J Respir Crit Care Med. 2020;201:e17-e18.
    PubMed    
    
    
    February 2020
43. NAIR GB, Castillo E, Myzuik N, Grills I, et al
    Differential Ventilation Pattern on Novel Functional Imaging in a Patient with Unilateral Bronchial Obstruction Caused by Adenoid Cystic Carcinoma.
    Am J Respir Crit Care Med. 2020;201:e6-e7.
    PubMed    
    
    
    January 2020
44. MARTINEZ-ZAYAS G, Almeida FA, Simoff MJ, Yarmus L, et al
    A Prediction Model to Help with Oncologic Mediastinal Evaluation for Radiation: HOMER.
    Am J Respir Crit Care Med. 2020;201:212-223.
    PubMed     Abstract available
    
    
    
45. BURNETT-HARTMAN AN, Wiener RS
    Lessons Learned to Promote Lung Cancer Screening and Pre-Empt Worsening Lung Cancer Disparities.
    Am J Respir Crit Care Med. 2020 Jan 6. doi: 10.1164/rccm.201912-2398.
    PubMed    
    
    
    November 2019
46. NISHIZAWA S, Tobino K
    Asymptomatic Tuberculous Pleurisy Mimicking Mesothelioma.
    Am J Respir Crit Care Med. 2019 Nov 25. doi: 10.1164/rccm.201906-1223.
    PubMed    
    
    
    
47. YAMASAKI M, Taniwaki M, Kawamoto K, Matsumoto N, et al
    Durvalumab-Induced Organizing Pneumonia with a Diffuse Micronodular Pattern in a Lung Cancer Patient.
    Am J Respir Crit Care Med. 2019 Nov 11. doi: 10.1164/rccm.201907-1310.
    PubMed    
    
    
    September 2019
48. HARBER P
    Asbestos, Pleural Plaques, and Lung Cancer: Untangling the Relationships.
    Am J Respir Crit Care Med. 2019 Sep 20. doi: 10.1164/rccm.201908-1676.
    PubMed    
    
    
    
49. WATANABE H, Powell CA
    Sequencing Lung Cancer's Sequence.
    Am J Respir Crit Care Med. 2019;200:657-659.
    PubMed    
    
    
    
50. SEARS CR, Peikert T, Possick JD, Naidoo J, et al
    Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement.
    Am J Respir Crit Care Med. 2019;200:e31-e43.
    PubMed     Abstract available
    
    
    August 2019
51. BRIMS FJ, Kong K, Harris EJ, Sodhi-Berry N, et al
    Pleural Plaques and the Risk of Lung Cancer in Asbestos-exposed Subjects.
    Am J Respir Crit Care Med. 2019 Aug 21. doi: 10.1164/rccm.201901-0096.
    PubMed     Abstract available
    
    
    July 2019
52. FISCH AS, Fintelmann FJ, Garcia-Moliner ML, Gaissert HA, et al
    Systemic Amyloidosis Mimicking Lung Cancer.
    Am J Respir Crit Care Med. 2019 Jul 26. doi: 10.1164/rccm.201812-2261.
    PubMed    
    
    
    June 2019
53. LI HY, Carr LL
    Predictive Biomarkers of Response to Src Inhibitors in Lung Cancer: Getting to YES1.
    Am J Respir Crit Care Med. 2019 Jun 17. doi: 10.1164/rccm.201905-1092.
    PubMed    
    
    
    
54. GARMENDIA I, Pajares MJ, Hermida-Prado F, Ajona D, et al
    YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
    Am J Respir Crit Care Med. 2019 Jun 5. doi: 10.1164/rccm.201807-1292.
    PubMed     Abstract available
    
    
    May 2019
55. ALLINSON JP, Brown J, Gibb K, Navani N, et al
    Immunotherapy in Non-Small Cell Lung Cancer. Which Patients and at Which Stage?
    Am J Respir Crit Care Med. 2019;199:1277-1279.
    PubMed    
    
    
    
56. TAGUCHI A, Arenberg D
    Harnessing Immune Response to Malignant Lung Nodules. Promise and Challenges.
    Am J Respir Crit Care Med. 2019;199:1184-1186.
    PubMed    
    
    
    March 2019
57. KADARA H, Sivakumar S, Jakubek Y, San Lucas FA, et al
    Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer.
    Am J Respir Crit Care Med. 2019 Mar 21. doi: 10.1164/rccm.201806-1178.
    PubMed     Abstract available
    
    
    February 2019
58. CHRISTENSON S, Hersh CP
    Found in Translation: Multi-omics Assessment of the COPD-Lung Cancer Interaction.
    Am J Respir Crit Care Med. 2019 Feb 12. doi: 10.1164/rccm.201901-0156.
    PubMed    
    
    
    
59. PIEDIMONTE G
    Taking Precise Aim at Lung Disease.
    Am J Respir Crit Care Med. 2019;199:255-256.
    PubMed    
    
    
    January 2019
60. MYC LA, Girton MR, Stoler MH, Davis EM, et al
    Necrobiotic Pulmonary Nodules of Crohn's Disease in a Patient Receiving Vedolizumab.
    Am J Respir Crit Care Med. 2019;199:e1-e2.
    PubMed    
    
    
    
61. NINAN N, Christ C, Daroca P
    Polypoid Endobronchial Cavernous Venous Hemangioma.
    Am J Respir Crit Care Med. 2019;199:113-114.
    PubMed    
    
    
    November 2018
62. THOMSON CC, Mckee AB
    American Thoracic Society/American Lung Association Lung Cancer Screening Implementation Guide.
    Am J Respir Crit Care Med. 2018;198:1120-1121.
    PubMed    
    
    
    October 2018
63. KIM HR, Park SM, Seo SU, Jung I, et al
    The Ratio of Peripheral Regulatory T Cells to Lox-1(+) PMN-MDSC Predicts the Early Response to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer Patients.
    Am J Respir Crit Care Med. 2018 Oct 19. doi: 10.1164/rccm.201808-1502.
    PubMed    
    
    
    July 2018
64. ZHAO Y, Johnson WE
    Exploring Host-Microbe Interactions in Lung Cancer.
    Am J Respir Crit Care Med. 2018 Jul 31. doi: 10.1164/rccm.201807-1225.
    PubMed    
    
    
    
65. TORRES M, Campillo N, Nonaka PN, Montserrat JM, et al
    Aging Reduces Intermittent Hypoxia-induced Lung Carcinoma Growth in a Mouse Model of Sleep Apnea.
    Am J Respir Crit Care Med. 2018 Jul 17. doi: 10.1164/rccm.201805-0892.
    PubMed    
    
    
    
66. RIVERA MP, Tanner NT, Silvestri GA, Detterbeck FC, et al
    Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement.
    Am J Respir Crit Care Med. 2018;198:e3-e13.
    PubMed     Abstract available
    
    
    June 2018
67. TSAY JJ, Wu BG, Badri MH, Clemente JC, et al
    Airway Microbiota Is Associated with Up-Regulation of the PI3K Pathway in Lung Cancer.
    Am J Respir Crit Care Med. 2018 Jun 4. doi: 10.1164/rccm.201710-2118.
    PubMed     Abstract available
    
    
    May 2018
68. FRIDLENDER ZG
    Myeloid Regulatory Cells - New and Exciting Players in the Immunology of Lung Cancer.
    Am J Respir Crit Care Med. 2018 May 14. doi: 10.1164/rccm.201804-0742.
    PubMed    
    
    
    
69. BEATTIE J, Yarmus L, Wahidi M, Rivera MP, et al
    The Immune Landscape of Non-Small Cell Lung Cancer: Utility of Cytologic and Histologic Samples Obtained Through Minimally Invasive Pulmonary Procedures.
    Am J Respir Crit Care Med. 2018 May 14. doi: 10.1164/rccm.201712-2539.
    PubMed     Abstract available
    
    
    April 2018
70. YAMAUCHI Y, Safi S, Blattner C, Rathinasamy A, et al
    Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-small-cell Lung Cancer.
    Am J Respir Crit Care Med. 2018 Apr 4. doi: 10.1164/rccm.201708-1707.
    PubMed     Abstract available
    
    
    March 2018
71. SALEHI-RAD R, Dubinett SM
    Understanding the Hurdles in Lung Cancer Immunotherapy in the Context of Chronic Obstructive Pulmonary Disease.
    Am J Respir Crit Care Med. 2018 Mar 28. doi: 10.1164/rccm.201803-0523.
    PubMed    
    
    
    
72. BITON J, Ouakrim H, Dechartres A, Alifano M, et al
    Impaired Tumor-infiltrating T Cells in Patients with COPD Impacts Lung Cancer Response to PD-1 Blockade.
    Am J Respir Crit Care Med. 2018 Mar 8. doi: 10.1164/rccm.201706-1110.
    PubMed     Abstract available
    
    
    February 2018
73. LU M, Zhu X, Shen N
    Endotracheal and Endobronchial Metastases of Small Cell Lung Cancer.
    Am J Respir Crit Care Med. 2018 Feb 28. doi: 10.1164/rccm.201708-1773.
    PubMed    
    
    
    January 2018
74. ROMAN J
    Complementing Lung Cancer: How Tumor Cells Coopt the Host Complement System to Reach Bone.
    Am J Respir Crit Care Med. 2018 Jan 24. doi: 10.1164/rccm.201801-0032.
    PubMed    
    
    
    
75. AJONA D, Zandueta C, Corrales L, Moreno H, et al
    Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.
    Am J Respir Crit Care Med. 2018 Jan 12. doi: 10.1164/rccm.201703-0660.
    PubMed     Abstract available
    
    
    December 2017
76. KORDE A, Jin L, Zhang JG, Ramaswamy A, et al
    Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.
    Am J Respir Crit Care Med. 2017;196:1443-1455.
    PubMed     Abstract available
    
    
    November 2017
77. RAMPINELLI C, Spitaleri G, Passaro A, Pochesci A, et al
    Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.
    Am J Respir Crit Care Med. 2017;196:1349-1350.
    PubMed    
    
    
    
78. KATHURIA H, Detterbeck FC, Fathi JT, Fennig K, et al
    Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement.
    Am J Respir Crit Care Med. 2017;196:1202-1212.
    PubMed     Abstract available
    
    
    October 2017
79. DUBINETT SM, Spira AE
    Impact of COPD on Immune-based Treatment for Lung Cancer: Moving Towards Disease Interception.
    Am J Respir Crit Care Med. 2017 Oct 26. doi: 10.1164/rccm.201710-2065.
    PubMed    
    
    
    
80. JOSEPH AM, Rothman AJ, Almirall D, Begnaud A, et al
    Lung Cancer Screening and Smoking Cessation Clinical Trials: SCALE Collaboration.
    Am J Respir Crit Care Med. 2017 Oct 4. doi: 10.1164/rccm.201705-0909.
    PubMed     Abstract available
    
    
    
81. MAZZONE PJ, Sears CR, Arenberg DA, Gaga M, et al
    Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement.
    Am J Respir Crit Care Med. 2017;196:e15-e29.
    PubMed     Abstract available
    
    
    September 2017
82. TANNER NT, Dai L, Bade BC, Gebregziabher M, et al
    Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
    Am J Respir Crit Care Med. 2017;196:602-608.
    PubMed     Abstract available
    
    
    
83. KIM CH, Jeong JS, Kim SR, Choe YH, et al
    Coexistence of Mediastinal Castleman Disease with Spindle Cell Carcinoma of the Lung.
    Am J Respir Crit Care Med. 2017;196:652-654.
    PubMed    
    
    
    August 2017
84. MILLER R, Mudambi L, Vial MR, Kalhor N, et al
    Radiation-induced Angiosarcoma as a Cause of Pleural Effusion.
    Am J Respir Crit Care Med. 2017;196:e10-e11.
    PubMed    
    
    
    
85. CIONE E, Gallelli L
    Direct Detection of Circulating MicroRNAs Unveiled the Absence of MicroRNA-218-5p in Smoker Subjects.
    Am J Respir Crit Care Med. 2017;196:532.
    PubMed    
    
    
    
86. JOSHI KP, Kaphle U, Steliga MA, Bartter T, et al
    Inflammatory Myo-fibroblastic Tumor of the Lung: A Rare Primary Lung Cancer.
    Am J Respir Crit Care Med. 2017 Aug 10. doi: 10.1164/rccm.201703-0538.
    PubMed    
    
    
    
87. ROMAN J
    On the "TRAIL" of a Killer: MMP12 in Lung Cancer.
    Am J Respir Crit Care Med. 2017;196:262-264.
    PubMed    
    
    
    
88. FIELDING D, Dalley AJ, Bashirzadeh F, Singh M, et al
    Next-Generation Sequencing of Endobronchial Ultrasound Transbronchial Needle Aspiration Specimens in Lung Cancer.
    Am J Respir Crit Care Med. 2017;196:388-391.
    PubMed    
    
    
    
89. DANDACHI N, Kelly NJ, Wood JP, Burton CL, et al
    Macrophage Elastase Induces TRAIL-mediated Tumor Cell Death through Its Carboxy-Terminal Domain.
    Am J Respir Crit Care Med. 2017;196:353-363.
    PubMed     Abstract available
    
    
    
90. CHADDHA U, Hagen JA, Yaghmour B
    Pulmonary Rhabdomyosarcoma Associated with Check-Valve Mechanism.
    Am J Respir Crit Care Med. 2017;196:e7-e9.
    PubMed    
    
    
    June 2017
91. TANNER NT, Gould MK
    Invasive Mediastinal Staging in Lung Cancer. Use a Prediction Model or Just Do It?
    Am J Respir Crit Care Med. 2017;195:1556-1558.
    PubMed    
    
    
    
92. RADZIKOWSKA E, Blasinska-Przerwa K, Szolkowska M, Miasko A, et al
    Kaposiform Lymphangiomatosis with Human Papillomavirus Infection.
    Am J Respir Crit Care Med. 2017;195:e47-e48.
    PubMed    
    
    
    May 2017
93. VACHANI A, Sequist LV, Spira A
    AJRCCM: 100-Year Anniversary. The Shifting Landscape for Lung Cancer: Past, Present, and Future.
    Am J Respir Crit Care Med. 2017;195:1150-1160.
    PubMed     Abstract available
    
    
    
94. SHANNON VR, Nanda AS, Middleton LP, Faiz SA, et al
    Pulmonary Mucinous Cystadenocarcinoma Presenting as Extensive Multifocal Cystic Lesions.
    Am J Respir Crit Care Med. 2017;195:1267-1268.
    PubMed    
    
    
    March 2017
95. DE GOEJE PL, Smit EF, Waasdorp C, Schram MT, et al
    Stereotactic Ablative Radiotherapy Induces Peripheral T-cell Activation in Early Stage Lung Cancer Patients.
    Am J Respir Crit Care Med. 2017 Mar 27. doi: 10.1164/rccm.201610-2178.
    PubMed    
    
    
    
96. CHANG IS, Jiang SS, Yang JC, Su WC, et al
    Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors.
    Am J Respir Crit Care Med. 2017;195:663-673.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: